164 related articles for article (PubMed ID: 10452990)
1. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase.
Mirmonsef P; Shelburne CP; Fitzhugh Yeatman C; Chong HJ; Ryan JJ
J Immunol; 1999 Sep; 163(5):2530-9. PubMed ID: 10452990
[TBL] [Abstract][Full Text] [Related]
2. IL-4 inhibits mouse mast cell Fc epsilonRI expression through a STAT6-dependent mechanism.
Ryan JJ; DeSimone S; Klisch G; Shelburne C; McReynolds LJ; Han K; Kovacs R; Mirmonsef P; Huff TF
J Immunol; 1998 Dec; 161(12):6915-23. PubMed ID: 9862725
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation.
Mekori YA; Metcalfe DD
J Immunol; 1994 Sep; 153(5):2194-203. PubMed ID: 7519644
[TBL] [Abstract][Full Text] [Related]
4. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand.
Mekori YA; Oh CK; Metcalfe DD
J Immunol; 1993 Oct; 151(7):3775-84. PubMed ID: 7690814
[TBL] [Abstract][Full Text] [Related]
5. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells.
Sillaber C; Strobl H; Bevec D; Ashman LK; Butterfield JH; Lechner K; Maurer D; Bettelheim P; Valent P
J Immunol; 1991 Dec; 147(12):4224-8. PubMed ID: 1721642
[TBL] [Abstract][Full Text] [Related]
6. IL-4 inhibits the production of TNF-alpha and IL-12 by STAT6-dependent and -independent mechanisms.
Levings MK; Schrader JW
J Immunol; 1999 May; 162(9):5224-9. PubMed ID: 10227996
[TBL] [Abstract][Full Text] [Related]
7. IL-4 preferentially activates a novel STAT6 isoform in mast cells.
Sherman MA; Secor VH; Brown MA
J Immunol; 1999 Mar; 162(5):2703-8. PubMed ID: 10072514
[TBL] [Abstract][Full Text] [Related]
8. Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3.
Smith TJ; Ducharme LA; Weis JH
Eur J Immunol; 1994 Apr; 24(4):822-6. PubMed ID: 7512032
[TBL] [Abstract][Full Text] [Related]
9. Stem cell factor activates STAT-5 DNA binding in IL-3-derived bone marrow mast cells.
Ryan JJ; Huang H; McReynolds LJ; Shelburne C; Hu-Li J; Huff TF; Paul WE
Exp Hematol; 1997 Apr; 25(4):357-62. PubMed ID: 9131012
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression.
Heath VL; Murphy EE; Crain C; Tomlinson MG; O'Garra A
Eur J Immunol; 2000 Sep; 30(9):2639-49. PubMed ID: 11009098
[TBL] [Abstract][Full Text] [Related]
11. Mouse bone marrow-derived mast cells undergo exocytosis, prostanoid generation, and cytokine expression in response to G protein-activating polybasic compounds after coculture with fibroblasts in the presence of c-kit ligand.
Ogasawara T; Murakami M; Suzuki-Nishimura T; Uchida MK; Kudo I
J Immunol; 1997 Jan; 158(1):393-404. PubMed ID: 8977215
[TBL] [Abstract][Full Text] [Related]
12. IL-4 enhances IL-10 gene expression in murine Th2 cells in the absence of TCR engagement.
Schmidt-Weber CB; Alexander SI; Henault LE; James L; Lichtman AH
J Immunol; 1999 Jan; 162(1):238-44. PubMed ID: 9886391
[TBL] [Abstract][Full Text] [Related]
13. BCL-6-deficient mice reveal an IL-4-independent, STAT6-dependent pathway that controls susceptibility to infection by Leishmania major.
Dent AL; Doherty TM; Paul WE; Sher A; Staudt LM
J Immunol; 1999 Aug; 163(4):2098-103. PubMed ID: 10438949
[TBL] [Abstract][Full Text] [Related]
14. Differential responsiveness of purified mouse c-kit+ mast cells and their progenitors to IL-3 and stem cell factor.
Lantz CS; Huff TF
J Immunol; 1995 Oct; 155(8):4024-9. PubMed ID: 7561112
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids inhibit the cytokine-induced proliferation of mast cells, the high affinity IgE receptor-mediated expression of TNF-alpha, and the IL-10-induced expression of chymases.
Eklund KK; Humphries DE; Xia Z; Ghildyal N; Friend DS; Gross V; Stevens RL
J Immunol; 1997 May; 158(9):4373-80. PubMed ID: 9127001
[TBL] [Abstract][Full Text] [Related]
16. Cell type-specific deficiency of c-kit gene expression in mutant mice of mi/mi genotype.
Isozaki K; Tsujimura T; Nomura S; Morii E; Koshimizu U; Nishimune Y; Kitamura Y
Am J Pathol; 1994 Oct; 145(4):827-36. PubMed ID: 7524330
[TBL] [Abstract][Full Text] [Related]
17. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
Beghini A; Cairoli R; Morra E; Larizza L
Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
[TBL] [Abstract][Full Text] [Related]
18. Internalization of Kit together with stem cell factor on human fetal liver-derived mast cells: new protein and RNA synthesis are required for reappearance of Kit.
Shimizu Y; Ashman LK; Du Z; Schwartz LB
J Immunol; 1996 May; 156(9):3443-9. PubMed ID: 8617971
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-kit and stem cell factor mRNA in liver specimens from healthy adult dogs.
Morimoto M; Tsujimura T; Kanakura Y; Kitamura Y; Matsuda H
Am J Vet Res; 1998 Mar; 59(3):363-6. PubMed ID: 9522959
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
